Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilg

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Gut|July 1, 1995
Serum neopterin concentrations in chronic liver diseaseA Wilmer, B Nölchen, H Tilg, et al.
Hepatology (Baltimore, Md.)|November 1, 1993
Circulating interleukin-1 and tumor necrosis factor antagonists in liver diseaseH Tilg, W Vogel, C J Wiedermann, et al.
Immunology Letters|January 1, 1985
Evaluation of spontaneous lymphocyte proliferation by single cell autoradiography in human allograft recipientsE Leiter, R Pfister, H Tilg, et al.
Clinical Nephrology|May 1, 1988
Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipientsW E Aulitzky, H Tilg, D Niederwieser, et al.
European Cytokine Network|April 22, 1999
Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapyE Vannier, A Kaser, M B Atkins, et al.
Journal of Immunological Methods|August 9, 1993
A method for the detection of erythrocyte-bound interleukin-8 in humans during interleukin-1 immunotherapyH Tilg, D Pape, E Trehu, et al.
Transplantation|April 1, 1992
Urinary and pancreatic juice neopterin excretion after combined pancreas-kidney transplantationH Tilg, A Königsrainer, R Krausler, et al.
Annals of Hematology|February 1, 1991
Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2W E Aulitzky, H Tilg, W Vogel, et al.
Cytokine|March 1, 1994
Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humansH Tilg, E Trehu, L Shapiro, et al.
Journal of Hepatology|March 1, 1992
Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantationH Tilg, U Westhoff, W Vogel, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Gut|July 1, 1995
Serum neopterin concentrations in chronic liver diseaseA Wilmer, B Nölchen, H Tilg, et al.
Hepatology (Baltimore, Md.)|November 1, 1993
Circulating interleukin-1 and tumor necrosis factor antagonists in liver diseaseH Tilg, W Vogel, C J Wiedermann, et al.
Immunology Letters|January 1, 1985
Evaluation of spontaneous lymphocyte proliferation by single cell autoradiography in human allograft recipientsE Leiter, R Pfister, H Tilg, et al.
Clinical Nephrology|May 1, 1988
Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipientsW E Aulitzky, H Tilg, D Niederwieser, et al.
European Cytokine Network|April 22, 1999
Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapyE Vannier, A Kaser, M B Atkins, et al.
Journal of Immunological Methods|August 9, 1993
A method for the detection of erythrocyte-bound interleukin-8 in humans during interleukin-1 immunotherapyH Tilg, D Pape, E Trehu, et al.
Transplantation|April 1, 1992
Urinary and pancreatic juice neopterin excretion after combined pancreas-kidney transplantationH Tilg, A Königsrainer, R Krausler, et al.
Annals of Hematology|February 1, 1991
Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2W E Aulitzky, H Tilg, W Vogel, et al.
Cytokine|March 1, 1994
Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humansH Tilg, E Trehu, L Shapiro, et al.
Journal of Hepatology|March 1, 1992
Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantationH Tilg, U Westhoff, W Vogel, et al.
Pageof 15